These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725 [TBL] [Abstract][Full Text] [Related]
45. [Relation between insulin resistance and small, dense lipoproteins with low density and the development of atherosclerosis in type 2 diabetes mellitus]. Fábryová L; Cagán S Bratisl Lek Listy; 1998; 99(3-4):138-45. PubMed ID: 9919742 [TBL] [Abstract][Full Text] [Related]
46. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Chapman MJ; Guérin M; Bruckert E Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339 [TBL] [Abstract][Full Text] [Related]
47. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). Vakkilainen J; Steiner G; Ansquer JC; Aubin F; Rattier S; Foucher C; Hamsten A; Taskinen MR; Circulation; 2003 Apr; 107(13):1733-7. PubMed ID: 12665498 [TBL] [Abstract][Full Text] [Related]
48. The atherogenic role of triglycerides and small, dense low density lipoproteins: impact of ciprofibrate therapy. Chapman MJ; Bruckert E Atherosclerosis; 1996 Jul; 124 Suppl():S21-8. PubMed ID: 8831912 [TBL] [Abstract][Full Text] [Related]
49. Surrogate lipid markers for small dense low-density lipoprotein particles in overweight youth. Burns SF; Lee SJ; Arslanian SA J Pediatr; 2012 Dec; 161(6):991-6. PubMed ID: 22809659 [TBL] [Abstract][Full Text] [Related]
50. Low density lipoprotein particle size and risk factors of insulin resistance syndrome. Friedlander Y; Kidron M; Caslake M; Lamb T; McConnell M; Bar-On H Atherosclerosis; 2000 Jan; 148(1):141-9. PubMed ID: 10580180 [TBL] [Abstract][Full Text] [Related]
51. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia. Kostapanos MS; Milionis HJ; Lagos KG; Rizos CB; Tselepis AD; Elisaf MS Eur J Pharmacol; 2008 Aug; 590(1-3):327-32. PubMed ID: 18585701 [TBL] [Abstract][Full Text] [Related]
52. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy. Rizzo M; Trepp R; Berneis K; Christ ER Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496 [TBL] [Abstract][Full Text] [Related]
53. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863 [TBL] [Abstract][Full Text] [Related]
54. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial. Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563 [TBL] [Abstract][Full Text] [Related]
56. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia. Patti L; Maffettone A; Iovine C; Marino LD; Annuzzi G; Riccardi G; Rivellese AA Atherosclerosis; 1999 Oct; 146(2):361-7. PubMed ID: 10532692 [TBL] [Abstract][Full Text] [Related]
57. The role of small, dense low density lipoprotein (LDL): a new look. Packard C; Caslake M; Shepherd J Int J Cardiol; 2000 Jun; 74 Suppl 1():S17-22. PubMed ID: 10856769 [TBL] [Abstract][Full Text] [Related]
58. The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease. Soedamah-Muthu SS; Colhoun HM; Thomason MJ; Betteridge DJ; Durrington PN; Hitman GA; Fuller JH; Julier K; Mackness MI; Neil HA; Atherosclerosis; 2003 Apr; 167(2):243-55. PubMed ID: 12818407 [TBL] [Abstract][Full Text] [Related]